TPDB

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB41041

Peptide_Name

Peptide 1a

Activity

Anticancer Antihypertensive Umami

Activity_category_statistics

Cardiometabolic peptides Cancer-related peptides Food sensory peptides

Database_Source

CancerPPD 2.0 AHTPDB AHTpin Peptipedia Tastepeptides-Meta

Sequence_Type

standard

Has_Modification No

Description A 2-aa standard natural multi-activity (Anticancer, Antihypertensive, and Umami) peptide sequence curated from CancerPPD 2.0, AHTPDB, AHTpin, and other sources, with an available 3D structural model.

Modification

N-terminal: 4-(methylsulfonyl)benzoic acid

Sequence

FE

FASTA

>TPDB41041|Anticancer;Antihypertensive;Umami|length=2
FE

Formula C14H18N2O5

Absent Amino Acids ARNDCQGHILKMPSTWYV

Common Amino Acids EF

Mass 294.31

PI 3.29

Basic Residues 0

Acidic Residues 1

Hydrophobic Residues 1

Net Charge -1

Boman Index 0.89

Hydrophobicity -0.350

Aliphatic Index 0.00

Half Life

Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min

Extinction Coefficient Cystines 0

Absorbance 280nm 0.00

Polar Residues 0

number

0

A

0

R

0

N

0

D

0

C

1

E

0

Q

0

G

0

H

0

I

0

L

0

K

0

M

1

F

0

P

0

S

0

T

0

W

0

Y

0

V

Amino Acid Distribution

A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0

Length

2

Formula

C14H18N2O5

Mass

294.31

PI

3.29

Net Charge

-1

Boman Index

0.89

Hydrophobicity

-0.350

C_terminal_Modification

Free

Chirality

L

Linear_or_Cyclic

Linear

N_terminal_Modification

4-(methylsulfonyl)benzoic acid

Nature

Antiproliferative, Anticancer

Origin

Synthetic

Evidence 1 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 64.4 ± 0.03 µM

Detail Source Activity Anticancer

Activity Measurement 64.4

Target

Cancer Type Breast Cancer

Cell Line MCF-7

Tissue Affected Breast

Assay & Model

Assay MTT assay

Testing Time 48-h

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2017

Other

Source Activity Label	Source Definition
Anticancer	CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.

Evidence 2 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 5.7 ± 0.04 µM

Detail Source Activity Anticancer

Activity Measurement 5.7

Target

Cancer Type Liver Cancer

Cell Line HepG-2

Tissue Affected Liver

Assay & Model

Assay MTT assay

Testing Time 48-h

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2017

Evidence 3 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 13.9 ± 0.03 µM

Detail Source Activity Anticancer

Activity Measurement 13.9

Target

Cancer Type Lung Cancer

Cell Line A-549

Tissue Affected Lung

Assay & Model

Assay MTT assay

Testing Time 48-h

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2017

Evidence 4 Activity

Activity

Activity Endpoint IC50

Activity Raw

IC50 = 21.4 ± 0.02 µM

Detail Source Activity Anticancer

Activity Measurement 21.4

Target

Cancer Type Cervical Cancer

Cell Line HeLa

Tissue Affected Cervix

Assay & Model

Assay MTT assay

Testing Time 48-h

Source & Reference

Database Source CancerPPD 2.0

Source CancerPPD2

Year 2017